¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21
±³À°ÀÏÀÚ : 2021-08-21
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 School of Breast Disease
ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060  
À̸ÞÀÏ : kbcs@kbcs.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ08:30~08:55 Breast imaging: MMG Tomo US  ½ÅÈñÁ¤(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ08:55~09:20 Breast imaging: MRI and Other Breast Imaging Tool  ¼Û¼ºÀº(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ09:20~09:45 Breast pathology: surgical pathology issues of practical importance  À¯ÇѼ®(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ09:45~10:10 Breast cancer staging & biomarker  ÀÌÀº½Å(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ10:10~10:35 Management of benign breast disease  È«¼öÁ¤(¾Æ»êÀ¯¿Ü°ú) 
È޽Ġ08-21 ¿Â¶óÀΠ10:35~10:55 È޽Ġ () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ10:55~11:20 Surgical Consideration for the primary tumor: mastectomy & BCS, oncoplastic procedure  ¹Ú¼º¹Î(ÃæºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ11:20~11:45 Surgical Consideration for the axilla: SLNBx & ALND  ÀÌÇѺ°(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ11:45~12:10 Introduction of endoscopic & robotic breast surgery  ±èÁö¿¹(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ12:10~12:35 Adjuvant radiation therapy after breast conserving therapy  ±è³ª¸®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ12:35~13:00 Postmastectomy radiation and RT in metastatic breast cancer  ±è±Ôº¸(ÀÌ´ë¸ñµ¿º´¿ø) 
½Ä»ç 08-21 ¿Â¶óÀΠ13:00~14:00 ½Ä»ç  () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ14:00~14:30 Adjuvant/neoadjuvant chemotherapy  ÀÌ´ë¿ø(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ14:30~15:00 Adjuvant/neoadjuvant endocrine therapy  Á¤ÀçÇÐ(À»Áö´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ15:00~15:30 Adjuvant/neoadjuvant targeted therapy  ±è¹Îȯ(¼¼ºê¶õ½ºº´¿ø) 
È޽Ġ08-21 ¿Â¶óÀΠ15:30~15:50 È޽Ġ () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ15:50~16:20 Emerging therapy for TN breast cancer  ÀÓ½ÂÅÃ(¿øÁÖ¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ16:20~16:50 Metastatic HER2 positive breast cancer  ¼­°æÁø(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ16:50~17:20 Hormone dependent metastatic breast cancer  À̼öÀÌ(µ¿¾Æ´ëÇб³º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ºÎ»ê¼Ò¾Æû¼Ò³â°ú Áöȸ ½ÉÆ÷Áö¾ö : 2021-08-21
´ÙÀ½±Û ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 8¿ù EGDM (Essential Guideline to Diabetes Management) : 2021-08-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
120 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø 2018³â È£½ºÇǽºÀÇ·á±â°ü Á¾»çÀÚ º¸¼ö±³À°°úÁ¤ : 2018-08-25 0 1,437 2018-07-28
119 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ±³À°ÀÚ ¼¼¹Ì³ª : 2018-08-25 0 666 2018-07-28
118 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease(Day 1) : 2018-08-25 0 578 2018-07-28
117 ´ëÀü ´ëÇѳëÀκ´ÇÐȸ ³ëÀÎȯÀÚÀÇ Ä¡·á¿Í º¯È­ÇÏ´Â ÀÇ·á : 2018-08-25 0 1,182 2018-07-28
116 ºÎ»ê 2018³â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ NIV ¿öÅ©¼¥ : 2018-08-25 0 892 2018-07-28
115 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-25 0 619 2018-07-28
114 ¼­¿ï Çѱ¹¿©ÀÚÀÇ»çȸ ¿°Áõ¼º Àå Áúȯ Áø´Ü°ú Ä¡·á / ³»½Ã°æ ¹ßÀü ¿ª»ç : 2018-08-25 0 539 2018-07-28
113 ´ë±¸ ´ëÇѵÎÅëÇÐȸ ´ë±¸, °æºÏÁö¿ª º¸¼ö±³À°(¸¸¼ºÆíµÎÅë Áø´Ü ¹× Ä¡·á 6 ´Ü°è) : 2018-08-25 0 757 2018-07-28
112 °æ±â Á¦ 7ȸ ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-08-25 0 611 2018-07-28
111 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó ¿ÀÀü session(8.25) : 2018-08-25 0 998 2018-07-28
110 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó Interactive workshop(8.25) : 2018-08-25 0 700 2018-07-28
109 ±¤ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦99Â÷ Àü³²ºÏÁöȸ ¿¬¼ö°­Á : 2018-08-25 0 621 2018-07-28
108 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ East Asian Conference of Neurointervention 2018 : 2018-08-25 0 255 2018-07-28
107 ¼­¿ï 2018³â Á¦11ȸ ¼­¿ï´ëÇб³º´¿ø ÀçÈ°ÀÇÇаú ¿¬¼ö°­Á : 2018-08-25 0 542 2018-07-28
106 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/25) : 2018-08-25 0 267 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷